934240-31-0
934240-31-0 结构式
基本信息
(2S,5R)-5-(4-((2-氟苄基)氧基)苯基)吡咯烷-2-甲酰胺盐酸盐
(2S,5R)-2-吡咯烷甲酰胺-5-[4-[(2-氟苯基)甲氧基]苯基]盐酸盐(1:1)
Raxatrigine HCl
GSK-1014802 HCl
GSK-1014802 hydrochloride
Raxatrigine hydrochloride
CNV1014802 (hydrochloride)
CNV1014802(Raxatrigine) hydrochloride
Raxatrigine hydrochloride(GSK1014802)
Raxatrigine HCl (GSK1014802, CNV1014802)
GSK-1014802
GSK 1014802
CNV-1014802
CNV 1014802
物理化学性质
制备方法
934240-30-9
934240-31-0
以(2S,5R)-5-(4-((2-氟苄基)氧基)苯基)吡咯烷-2-甲酰胺(5.46 g,17.37 mmol)为原料,将其溶解于乙酸乙酯(140 mL)中,搅拌30分钟后过滤。向滤液中加入4M HCl的二恶烷溶液(6.51 mL,26.05 mmol),室温下搅拌反应20分钟,随后在冰浴中冷却15分钟。通过过滤收集生成的固体,用冷乙酸乙酯(2×20 mL)洗涤,先在35℃下真空干燥过夜,再在50℃下干燥2小时,得到灰白色固体产物(E1,5.87 g,收率96%)。LC-MS显示MH+ = 315(对应分子式C18H19FN2O2)。1H NMR(d6-DMSO)数据如下:δ 1.95-2.20(2H,m),2.30(2H,m),3.35(1H,s),4.30(1H,m),4.61(1H,m),5.18(2H,s),7.10(2H,d,J = 9 Hz),7.18-7.30(2H,m),7.40(1H,m),7.47(2H,d,J = 9 Hz),7.56(1H,s),7.72(1H,s),8.07(1H,s),10.60(1H,br s)。
参考文献:
[1] Patent: WO2016/102967, 2016, A1. Location in patent: Page/Page column 43
[2] Patent: WO2011/29762, 2011, A1. Location in patent: Page/Page column 23-24
[3] Patent: WO2007/42239, 2007, A1. Location in patent: Page/Page column 45
[4] Patent: WO2007/42239, 2007, A1. Location in patent: Page/Page column 45-46
[5] Patent: WO2007/42239, 2007, A1. Location in patent: Page/Page column 46
| 报价日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
| 2025/12/22 | HY-12796A | (2S,5R)-5-(4-((2-氟苄基)氧基)苯基)吡咯烷-2-甲酰胺盐酸盐 Raxatrigine hydrochloride | 934240-31-0 | 1 mg | 480元 |
| 2025/12/22 | HY-12796A | (2S,5R)-5-(4-((2-氟苄基)氧基)苯基)吡咯烷-2-甲酰胺盐酸盐 Raxatrigine hydrochloride | 934240-31-0 | 5mg | 1200元 |
| 2025/12/22 | HY-12796A | (2S,5R)-5-(4-((2-氟苄基)氧基)苯基)吡咯烷-2-甲酰胺盐酸盐 Raxatrigine hydrochloride | 934240-31-0 | 10mM * 1mLin DMSO | 1320元 |
